α‐Emitting cancer therapy using 211 At‐AAMT targeting LAT1-Reference-Cited by-同舟云学术

α‐Emitting cancer therapy using 211 At‐AAMT targeting LAT1

Published:2021-01-22 Issue:3 Volume:112 Page:1132-1140
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Kaneda‐Nakashima Kazuko¹²^ORCID,Zhang ZiJian²³,Manabe Yoshiyuki¹²³^ORCID,Shimoyama Atsushi¹²³^ORCID,Kabayama Kazuya¹²³^ORCID,Watabe Tadashi¹⁴^ORCID,Kanai Yoshikatsu¹⁵^ORCID,Ooe Kazuhiro¹⁴^ORCID,Toyoshima Atsushi¹²,Shirakami Yoshifumi¹²⁴,Yoshimura Takashi¹⁶^ORCID,Fukuda Mitsuhiro¹⁷,Hatazawa Jun¹⁴,Nakano Takashi¹⁷,Fukase Koichi¹²³^ORCID,Shinohara Atsushi¹²⁸

Affiliation:

1. Division of Science Institute for Radiation Sciences Osaka University Osaka Japan

2. MS‐CORE, PRC, Graduate School of Science Osaka University Osaka Japan

3. Laboratory for Natural Product Chemistry Department of Chemistry Graduate School of Science Osaka University Osaka Japan

4. Department of Nuclear Medicine and Tracer Kinetics Graduate School of Medicine Osaka University Osaka Japan

5. Department of Bio‐System Pharmacology Graduate School of Medicine Osaka University Osaka Japan

6. Radioisotope Research Center Institute for Radiation Sciences Osaka University Osaka Japan

7. Research Center for Nuclear Physics Osaka University Osaka Japan

8. Laboratory for Radiochemistry Department of Chemistry Graduate School of Science Osaka University Osaka Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14761

Reference29 articles.

1. Cancer statistics, 2020

2. Alpha-Emitters and Targeted Alpha Therapy in Oncology: from Basic Science to Clinical Investigations

3. Introduction of the targeted alpha therapy (with Radium-223) into clinical practice in Japan: learnings and implementation

4. Radium-223 for the treatment of bone metastases in castration-resistant prostate cancer: when and why

5. Treatment of brain metastases of castration-resistant prostate cancer with 225Ac-PSMA-617

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy;Molecular Metabolism;2024-06

2. Can current preclinical strategies for radiopharmaceutical development meet the needs of targeted alpha therapy?;European Journal of Nuclear Medicine and Molecular Imaging;2024-04-27

3. Neopentyl glycol-based radiohalogen-labeled amino acid derivatives for cancer radiotheranostics;EJNMMI Radiopharmacy and Chemistry;2024-02-26

4. L-type Amino Acid Transporter 1 as a Therapeutic Target in Pancreatic Cancer;Cancer Control;2024-01

5. Development and Utility of an Imaging System for Internal Dosimetry of Astatine-211 in Mice;Bioengineering;2023-12-26